Pharming Group N.V. Sponsored ADR (PHAR)

Last Closing Price: 14.59 (2025-08-28)

Income from Continuous Operations (Quarterly)

Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.

Pharming Group N.V. Sponsored ADR (PHAR) had Income from Continuous Operations of $4.60M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$93.20M
$4.60M
$9.00M
$84.20M
$82.40M
$10.80M
$-3.70M
$7.10M
$7.10M
$4.60M
Income from Continuous Operations
$4.60M
$4.60M
$4.60M
$10.80M
$13.50M
65.71M
76.67M
$0.07
$0.06
Balance Sheet Financials
$245.78M
$7.96M
$200.48M
$446.26M
$87.94M
$91.27M
$118.77M
$206.71M
$239.55M
$103.65M
$239.55M
68.51M
Cash Flow Statement Financials
$11.97M
$26.65M
$-9.48M
$54.94M
$92.09M
$37.15M
$6.05M
--
--
Fundamental Metrics & Ratios
2.79
--
--
0.28
0.40
90.34%
11.59%
11.59%
--
7.62%
4.94%
$11.56M
--
--
--
0.21
0.14
1.75
51.50
1.92%
4.44%
1.03%
1.39%
$3.50
$0.15
$0.16